| Source: |
| Type: |
| Also known as PTGER2 EP2 (Prostaglandin E2 receptor 2) is a receptor that plays a role in various cellular processes, including inflammation and cell growth. In cancer, EP2 has been implicated in tumor development and progression. Tumorigenic potential: -promote tumorigenesis by enhancing cell proliferation and survival -Increasing angiogenesis (formation of new blood vessels) -Suppressing apoptosis (programmed cell death) -Promoting invasion and metastasis Expression levels in cancer: Overexpressed in:Colorectal, Breast, Lung, Prostate, and Ovarian cancer (with generally poor prognosis) Underexpressed in:Some types of gastric cancer (correlated with improved overall survival) |
| 2503- | H2, | Brain Metastases Completely Disappear in Non-Small Cell Lung Cancer Using Hydrogen Gas Inhalation: A Case Report |
| - | Case Report, | Lung, | NA |
| 1019- | TQ, | Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation |
| - | vitro+vivo, | CRC, | LoVo |
| - | in-vitro, | Nor, | RAW264.7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:969 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid